Cutaneous Squamous Cell Carcinoma (CSCC): Clinical Trials

22 trials for Cutaneous Squamous Cell Carcinoma (CSCC), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 recruiting, 4 not yet recruiting, 1 active not recruiting, 1 approved for marketing. 5 Phase 2, 4 Phase 1, 2 Early Phase 1, 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 3, Not yet recruiting 2
Phase 14Recruiting 2, Terminated 1, Withdrawn 1
Early Phase 12Recruiting 2
Phase 32Recruiting 2
Not applicable1Recruiting 1

Follow Cutaneous Squamous Cell Carcinoma (CSCC): new trials by email Literature Review of Cutaneous Squamous Cell Carcinoma (CSCC) trials Research Report on Cutaneous Squamous Cell Carcinoma (CSCC)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Cemiplimab, Prednisone, Sirolimus - Kidney Transplant Recipient, Cutaneous Squamous Cell Carcinoma (CSCC)
Phase 2Not yet recruitingWashington University School of Medicine222026-11-302026-10-15
Flash Radiotherapy for Skin Cancer
FLASH radiotherapy, Conventional radiotherapy - Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC)
Phase 2RecruitingJules Bordet Institute602026-08-242026-11-17
D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab
Pretreatment D-dimer status - Cutaneous Squamous Cell Carcinoma (CSCC), Advanced Cutaneous Squamous Cell Carcinoma
Not yet recruitingUniversitätsklinikum Hamburg-Eppendorf1162026-08-012026-07-22
A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
KUP-101A - Cutaneous Melanoma, Mucosal Melanoma
Phase 1RecruitingKupando GmbH212026-07-032026-11-18
A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
Topical niacinamide 5% cream, Sunscreen - Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC)
Early Phase 1RecruitingMarissa Lobl202026-05-012026-06-05
Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma
Pucotenlimab, Becotatug Vedotin - Cutaneous Squamous Cell Carcinoma (CSCC)
Phase 2Not yet recruitingFudan University382026-01-092026-02-06
Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence
High-Frequency Ultrasound, Dermoscopy - Basal Cell Carcinoma of Skin, Cutaneous Squamous Cell Carcinoma (CSCC)
Not yet recruitingPaństwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji4002025-12-232026-01-23
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
tolododekin alfa - Cutaneous Squamous Cell Carcinoma (CSCC), Renal Transplant
Phase 1WithdrawnAnkyra Therapeutics, Inc2025-12-152026-06-25
Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.
Cemiplimab - Cutaneous Squamous Cell Carcinoma (CSCC)
RecruitingInstituto de Investigación Biomédica de Salamanca302025-07-172026-11-09
MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
Short course radiation, Active Surveillance - Cutaneous Squamous Cell Carcinoma (CSCC)
Phase 2RecruitingUniversity of Vermont Medical Center242025-06-042026-05-26
Towards Cure Via Only Ultra-short ICB in CSCC
Nivolumab, Ipilumimab - Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer
Phase 2RecruitingThe Netherlands Cancer Institute412025-05-142025-05-29
Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence
Adjuvant radiotherapy - Cutaneous Squamous Cell Carcinoma (CSCC)
Phase 3RecruitingCentre Leon Berard2662025-02-212026-04-24
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Cemiplimab, Standard of care - Cutaneous Squamous Cell Carcinoma (CSCC)
Phase 3RecruitingRegeneron Pharmaceuticals3692025-01-022026-09-16
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
Blood draw for the laboratory assessment - Skin Cancer, Melanoma (Skin Cancer)
Active not recruitingUniversity of Wisconsin, Madison202024-12-112026-05-29
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision
Fluzone Trivalent - Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC)
Early Phase 1RecruitingDana-Farber Cancer Institute252024-11-262026-10-19
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Blood Specimen Collection, Tumor Tissue Collection, Medical Record Review - Squamous Cell Carcinoma of Head and Neck, Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
RecruitingUniversity of California, San Francisco2502024-10-092025-12-12
A Study of VET3-TGI in Patients With Solid Tumors
VET3-TGI, Atezolizumab - Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer
Phase 1RecruitingKaliVir Immunotherapeutics602024-09-162026-11-17
Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study
Cutaneous Squamous Cell Carcinoma (CSCC)
RecruitingFondazione IRCCS Policlinico San Matteo di Pavia1202023-11-172025-03-17
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
BBI-355, Erlotinib, Futibatinib - Triple Negative Breast Cancer (TNBC), High Grade Serous Ovarian Carcinoma
Phase 1TerminatedBoundless Bio, Inc.852023-03-242026-08-19
Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment.
Systemic treatment - Cutaneous Squamous Cell Carcinoma (CSCC)
RecruitingUniversity Hospital, Lille15002021-07-092026-05-26

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Skin Neoplasms (7)  ·  Carcinoma, Basal Cell (6)  ·  Melanoma (3)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Squamous Cell (2)  ·  Head and Neck Neoplasms (2)  ·  Carcinoma, Renal Cell (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Keratosis, Actinic (1)  ·  Kidney Neoplasms (1)  ·  Leiomyosarcoma (1)  ·  Margins of Excision (1)  ·  Mesothelioma (1)  ·  Recurrence (1)

Broader conditions

Neoplasms (12)  ·  Neoplasms by Site (12)  ·  Carcinoma (9)  ·  Neoplasms by Histologic Type (9)  ·  Neoplasms, Glandular and Epithelial (9)  ·  Skin Diseases (9)  ·  Skin and Connective Tissue Diseases (9)  ·  Neoplasms, Basal Cell (6)  ·  Bronchial Neoplasms (3)  ·  Carcinoma, Bronchogenic (3)  ·  Lung Diseases (3)  ·  Lung Neoplasms (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neuroectodermal Tumors (3)

Interventions

cemiplimab (4)  ·  Blood Specimen Collection (2)  ·  Cetuximab (1)  ·  Dermoscopy (1)  ·  Erlotinib Hydrochloride (1)  ·  Histocompatibility Testing (1)  ·  Immunotherapy (1)  ·  Influenza Vaccines (1)  ·  Lymph Node Excision (1)  ·  Neoadjuvant Therapy (1)  ·  Niacinamide (1)  ·  Nivolumab (1)  ·  Prednisone (1)  ·  Radiotherapy, Adjuvant (1)  ·  Sirolimus (1)

Sponsors

Regeneron Pharmaceuticals (2)  ·  Ankyra Therapeutics, Inc (1)  ·  Boundless Bio, Inc. (1)  ·  Centre Leon Berard (1)  ·  Dana-Farber Cancer Institute (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Fudan University (1)  ·  Germans Trias i Pujol Hospital (1)  ·  Instituto de Investigación Biomédica de Salamanca (1)  ·  Jules Bordet Institute (1)  ·  KaliVir Immunotherapeutics (1)  ·  Kupando GmbH (1)  ·  Marissa Lobl (1)  ·  Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji (1)  ·  The Netherlands Cancer Institute (1)

Countries

United States (9)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  China (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)

Top investigators

Ann Silk, MD (1)  ·  George Ansstas, MD (1)  ·  Glenn Geidel, MD, MSc (1)  ·  Jason W Chan, MD (1)  ·  Joe Elassal, MD, MBA (1)  ·  Karam Khaddour, MD (1)  ·  Lotje Zuur, Prof. Dr. (1)  ·  Naoka Murakami, MD, PhD (1)  ·  Robert Doebele, MD, PhD (1)  ·  Vincent Ma, MD (1)

NIH funding

2025 (1), KL2TR002374-07 (1)